Table 2.
Secondary prevention research, n = 208
| Primary focus | Literature type | Countries/Geographic Regions Included | |
|---|---|---|---|
| Secondary Prevention | Screening Test Performance (N = 46) 11 VIA/VILI [194, 196, 197, 232, 278–284] 15 HPV Testing [163, 182–192, 285–287] 3 Cytology [288–290] 1 Colposcopy [291] 16 Comparison of 2+ tests [16, 193, 195, 198, 292–303] |
41 Original Research [182, 184–186, 188–198, 232, 278–293, 295, 296, 298–303] 4 Review Article [16, 187, 294, 297] Lessons Learned 1 Policy Papers [163] |
Africa (2) [285, 297], Developing Countries (4) [16, 284, 294, 302], Angola (1) [197], Botswana (1) [232], Burkina Faso (5) [194, 280, 282, 291, 298], Cameroon (4) [182, 193, 286, 300], Democratic Republic of Congo (3) [195, 198, 296], Republic of the Congo (6) [191, 194, 280, 282, 291, 298], Egypt (2) [186, 278], Gambia (1) [192], Ghana (1) [288], Guinea (5) [194, 280, 282, 291, 298], Ivory Coast (1) [190], Kenya (2) [184, 301], Mali (5) [194, 280, 282, 291, 298], Niger (5) [194, 280, 282, 291, 298], Nigeria (4) [279, 287, 289, 293], Rwanda (1) [294], South Africa (7) [163, 183, 187, 188, 290, 292, 299], Tanzania (2) [196, 295] |
| Screen-and-Treat (SNT) (N = 16) 8 VIA then Cryotherapy [63, 199–201, 304–307] 5 Other SNT methods [61, 308–311] 3 Guidelines/Overview [51, 202, 203] |
10 Original Research [61, 63, 200, 201, 305, 307–311] 2 Review [203, 304] 2 Lessons Learned [199, 202] 2 Policy [51,283 1,217] |
Global (1) [51], Africa (1) [203], Botswana (1) [307], Ghana (1) [63], Kenya (1) [61], Madagascar (1) [306], Malawi (1) [306], Nigeria (2) [306, 311],South Africa (2) [308, 310], Tanzania (1) [306], Uganda (2) [200, 306], Zambia (7) [199, 201, 202, 304–306, 309] | |
| Feasibility (N = 28) 2 Infrastructure [215, 220] 18 Provider Knowledge/Training/Attitudes [60, 82, 83, 208–211, 312–322] 8 Cost/Cost-effectiveness [59, 125, 212–214, 323–325] |
26 Original Research [59, 83, 125, 208–215, 220, 312–325] 2 Review [60, 82] 0 Lessons Learned 0 Policy |
Africa (3) [82, 125, 212], Cameroon (1) [313], Ghana (1) [323], Ivory Coast (1) [208], Kenya (2) [59, 325], Nigeria (11) [83, 211, 220, 312, 315–317, 319–321], South Africa (6) [59, 213, 214, 318, 324, 325], Tanzania (1) [209], LRC [60] | |
| Awareness and Utilization (N = 59) 44 Knowledge, Attitudes, Uptake [53, 70, 72, 74, 78–80, 204–207, 225, 326–357] 15 Determinants of Uptake [62, 73, 358–370] |
59 Original Research [53, 62, 70, 72–74, 78–80, 204–207, 225, 326–370] 0 Review 0 Lessons Learned 0 Policy |
Global (1) [368], Developing Countries (1) [328], Botswana (3) [72, 205, 349], Cameroon (1) [74], Ghana (2) [70, 326], Kenya (5) [204, 335, 340, 355, 358], Malawi (1) [53], Mozambique (1) [207], Morocco (1) [365], Nigeria (18) [78, 79, 225, 332–334, 337, 338, 342, 344–346, 348, 351, 352, 363, 366, 367], South Africa (12) [80, 327, 329, 330, 341, 347, 353, 356, 360, 361, 369], Sudan (1) [343], Tanzania (5) [62, 336, 362, 364, 370], Tunisia (1) [331] | |
| HIV-Positive Women (N = 18) 5 Service Integration [77, 84, 229–231] 9 Test Performance [371–379] 3 Knowledge, Attitudes, Uptake [75, 227, 228] 1 Screen-and-Treat [226] |
17 Original Research [75, 77, 84, 226–230, 371–379] 1 Review [231] 0 Lessons Learned 0 Policy |
Global (1) [231], Burkina Faso (1) [373], Cameroon (1) [230], Kenya (4) [229, 374, 376, 378], Nigeria (3) [75, 84, 227], South Africa (6) [226, 228, 371, 373, 375, 377], Uganda (1) [379], Tanzania (1) [77] | |
| Males and HPV Screening (N = 3) 1 Knowledge and Beliefs [221], 1 Male Partner Support [222], 1 Penile HPV Detection [223] |
3 Original Research [221–223] 0 Review 0 Lessons Learned 0 Policy |
Ghana (1) [221], Kenya (1) [223], Uganda (1) [222] | |
| Other (N = 38) 23 Program/Policy Implementation [54, 71, 216–219, 224, 380–395] 3 Screening Follow-Up [396, 397] and Side-effects [398] 5 Overview of Current Situation [123, 399–402] 7 Other Ethical Issues,[403] message development, [404] overviews,[69, 85, 405, 406] publication output [407] |
17 Original Research [71, 216, 217, 219, 224, 380, 381, 383–385, 388, 395–398, 403, 404] 14 Review [54, 69, 85, 123, 382, 391, 392, 394, 399, 400, 402, 405–407] 4 Lessons Learned [218, 386, 387, 393] 3 Policy [389, 390, 401] |
Africa (3) [391, 400, 405], Developing Countries (7) [54, 69, 85, 123, 382, 392, 406], Middle East/North Africa (1) [399], Ghana (2) [217, 401], Ivory Coast (1) [224], Kenya (2) [384, 403], Mali (1) [383], Mozambique (1) [216], Nigeria (6) [386–388, 393, 396, 398], South Africa (11) [71, 218, 219, 381, 385, 390, 394, 395, 402, 404, 407], Sudan (1) [389] | |
| Total N = 208 |
173 Original Research 23 Review Article 6 Lessons Learned 6 Policy Papers |
Global (3), Africa (9), Developing Countries (11), Middle East/North Africa (1), Angola (1), Botswana (5), Burkina Faso (6), Cameroon (7), Congo (9), Egypt (2), Gambia (1), Ghana (8), Guinea (5), Ivory Coast (3), Kenya (17), Madagascar (1), Malawi (2), Mali (6), Morocco (1), Mozambique (2), Niger (5), Nigeria (43), Rwanda (1), South Africa (45), Sudan (2),Tanzania (9), Tunisia (1), Uganda (4), Zambia (7), |